Researchers highlight harms of unnecessary diagnosis and unclear treatment pathways
1 Sep 15 8:30 AM · 9d ago · 3 articles · 1 post · 3 sources · development 1 of 1
Smith identified multiple risks: healthy people testing positive for biomarkers may never develop dementia; treatments have only been tested in people with mild cognitive impairment or dementia, not asymptomatic people; and there is no clear clinical pathway for what to do after a positive test. She also cited psychological burden, insurance implications, and treatment side effects as concerns.
“Healthy people who undergo these tests could be diagnosed with Alzheimer's disease but not go on to develop dementia. It is also not clear what to do next after testing positive.”
Dr. Jenna SmithDr. Jenna Smith University of Sydney public health researcherProf. Susan Kurrle President, Australian and New Zealand Society for Geriatric MedicineAlzheimer's Association Peak neurological body
The whole story articlesposts the bright band is this development · numbered dots are the others · click one to jump
Reported in the same hours no headline names this development itself — these 1 claim were published in its stretch
-
first by The Guardian, 8d ago · also The University of Sydney, Mediaweek, Guardian
2 more headlines
- Social media spreading misleading claims about Alzheimer’s blood tests, study finds The University of Sydney · 8d ago
- Social media is spreading misleading claims about Alzheimer’s blood tests Mediaweek · 8d ago
What people said 1 voice · verbatim
-
R
https://www. theguardian.com/australia-news /2026/sep/15/researchers-warn-social-media-driving-harmful-misuse-of-alzheimers-blood-tests .
All 1 developments of Researchers warn social media promoting risky Alzheimer's… →
MastodonNewswiresGoogle News